MedPath

Effects of barberry consumption on liver function and antioxidant capacity

Phase 2
Conditions
liver disease.
Toxic liver disease
Registration Number
IRCT2016101517756N9
Lead Sponsor
Vice Chancellery for Research of Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

university employee, age between 20 and 40, lack of a specific disease or use of antibiotics since two weeks from the study onset, non-use of alcohol or smoking, provision of informed consent; Exclusion criteria: suffering from a disease during the study, consumption of antibiotics and/or alcohol, or smoking during the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Antioxidant level. Timepoint: Before, 7 dats and 14 days after intervention. Method of measurement: Ferric Reducing Ability of Plasma (FRAP), Thiobarbituric acid reactive substances (TBARS).;Liver enzymes. Timepoint: Before, 7 dats and 14 days after intervention. Method of measurement: ALT, AST, ALK and bilirubin tests.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath